Product Recalls in Rhode Island

Product recalls affecting Rhode Island — including food, drugs, consumer products, medical devices, and vehicles distributed to Rhode Island. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,526 recalls have been distributed to Rhode Island in the last 12 months.

47,970 total recalls
2,526 in last 12 months

Showing 64416460 of 13,384 recalls

DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 15, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets 10 mg Recalled by Hetero Labs Limited Unit V Due...

The Issue: Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugAugust 14, 2018· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Diltiazem HCl Extended-release Capsules Recalled by Mylan Institutional,...

The Issue: Failed Impurities/Degradation Specifications; out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· Mckesson Corporation

Recalled Item: Megestrol Acetate Oral Suspension Recalled by Mckesson Corporation Due to...

The Issue: Supterpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: Cyclosporine 1% Human Eye Drops Recalled by Westlab Pharmacy, Inc. dba...

The Issue: Lack of Process Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: ADAA Cataract Drops Recalled by Westlab Pharmacy, Inc. dba Westlab Pharmacy...

The Issue: Lack of Process Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: Alprostadil 500 mcg/mL Injectable Recalled by Westlab Pharmacy, Inc. dba...

The Issue: Incorrect Product Formulation

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 9, 2018· Orexigen Therapeutics, Inc.

Recalled Item: Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets...

The Issue: Defective Container: Customer complaints of punctures in the bottle.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 8, 2018· Akorn, Inc.

Recalled Item: Azelastine HCl Ophthalmic Solution 0.05% Recalled by Akorn, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications:out-of-specification (OOS)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 7, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Diltiazem HCl Extended-Release Capsules Recalled by Mylan Pharmaceuticals...

The Issue: Failed Impurities/Degradation Specifications: Out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 7, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Diltiazem HCl Extended-Release Capsules Recalled by Mylan Pharmaceuticals...

The Issue: Failed Impurities/Degradation Specifications: Out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund